Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1344 ARTÍCULOS , VIENDO DEL 181 AL 195

Engineered antibody approaches for Alzheimer's disease immunotherapy

Robert R, Wark KL.

Arch Biochem Biophys. 2012 Oct 15;526(2):132-8. doi: 10.1016/j.abb.2012.02.022. Epub 2012 Mar 27.

Phospholipase C-η activity may contribute to Alzheimer's disease-associated calciumopathy

Popovics P, Stewart AJ.

J Alzheimers Dis. 2012;30(4):737-44. doi: 10.3233/JAD-2012-120241.

Integrating cytosolic phospholipase A₂ with oxidative/nitrosative signaling pathways in neurons: a novel therapeutic strategy for AD

Sun GY, He Y, Chuang DY, Lee JC, Gu Z, Simonyi A, Sun AY.

Mol Neurobiol. 2012 Aug;46(1):85-95. doi: 10.1007/s12035-012-8261-1. Epub 2012 Apr 3.

Pharmacoeconomics of Alzheimer's disease (AD) treatment with cholinesterase inhibitors

Versijpt J.

Acta Neurol Belg. 2012 Jun;112(2):141-5. doi: 10.1007/s13760-012-0062-9. Epub 2012 Apr 4.

Economic evaluation of treatment options in patients with Alzheimer's disease: a systematic review of cost-effectiveness analyses

Pouryamout L, Dams J, Wasem J, Dodel R, Neumann A.

Drugs. 2012 Apr 16;72(6):789-802. doi: 10.2165/11631830-000000000-00000.

Editorial: Anti Alzheimer agents

Hugel H.

Mini Rev Med Chem. 2012 May;12(5):363. doi: 10.2174/138955712800493889.

Alzheimer's disease and the amyloid β-protein

Walsh DM, Teplow DB.

Prog Mol Biol Transl Sci. 2012;107:101-24. doi: 10.1016/B978-0-12-385883-2.00012-6.

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature

Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, Hyman BT, Iwatsubo T, Jellinger KA, Jicha GA, Kövari E, Kukull WA, Leverenz JB, Love S, Mackenzie IR, Mann DM, Masliah E, McKee AC, Montine TJ, Morris JC, Schneider JA, Sonnen JA, Thal DR, Trojanowski JQ, Troncoso JC, Wisniewski T, Woltjer RL, Beach TG.

J Neuropathol Exp Neurol. 2012 May;71(5):362-81. doi: 10.1097/NEN.0b013e31825018f7.

Unraveling the early events of amyloid-β protein (Aβ) aggregation: techniques for the determination of Aβ aggregate size

Pryor NE, Moss MA, Hestekin CN.

Int J Mol Sci. 2012;13(3):3038-3072. doi: 10.3390/ijms13033038. Epub 2012 Mar 7.

[Difference in sundowning of wandering behavior in patients with Alzheimer disease and frontotemporal dementia]

Liao XY, Yamakawa M, Shigenobu K, Suto S, Makimoto K.

Zhonghua Yi Xue Za Zhi. 2012 Jan 17;92(3):160-4.

Synapses and Alzheimer's disease

Sheng M, Sabatini BL, Südhof TC.

Cold Spring Harb Perspect Biol. 2012 May 1;4(5):a005777. doi: 10.1101/cshperspect.a005777.

A controlled clinical trial on the effects of exercise on neuropsychiatric disorders and instrumental activities in women with Alzheimer's disease

Nascimento CM, Teixeira CV, Gobbi LT, Gobbi S, Stella F.

Rev Bras Fisioter. 2012 Jun;16(3):197-204. doi: 10.1590/s1413-35552012005000017. Epub 2012 Apr 12.

Recruitment, retention and other methodological issues related to clinical trials for Alzheimer's disease

Vellas B.

J Nutr Health Aging. 2012 Apr;16(4):330. doi: 10.1007/s12603-012-0043-y.

Representations and practices of prevention in elderly populations: investigating acceptance to participate in and adhesion to an intervention study for the prevention of Alzheimer's disease (ACCEPT study)--the need for a multidisciplinary approach

Andrieu S, Coley N, Gardette V, Subra J, Oustric S, Fournier T, Poulain JP, Coniasse-Brioude D, Igier V, Vellas B, Grand A; ACCEPT Study Group.

J Nutr Health Aging. 2012 Apr;16(4):352-4. doi: 10.1007/s12603-012-0045-9.

Recruitment strategies for preventive trials. The MAPT study (MultiDomain Alzheimer Preventive Trial)

Carrié I, van Kan GA, Gillette-Guyonnet S, Andrieu S, Dartigues JF, Touchon J, Dantoine T, Rouaud O, Bonnefoy M, Robert P, Cuffi MN, Bories L, Bordes S, Gasnier Y, Desclaux F, Sudres K, Pesce A, Vellas B.

J Nutr Health Aging. 2012 Apr;16(4):355-9. doi: 10.1007/s12603-012-0046-8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias